MediWound Reports Stronger-Than-Expected Q2 Revenue and Reduced Losses

MediWound Ltd. (NASDAQ: MDWD) released its second-quarter financial results, reporting revenues of US$3.1 million, which surpassed analyst expectations. The company also narrowed its statutory losses to US$0.57 per share, performing 25% better than forecasts. These results indicate improved financial performance for the biotechnology firm.